News und Analysen
![Form 8.3 - The Vanguard Group, Inc.: Allergan plc](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
![DGAP-News: aap Implantate AG: GJ/19: Gutes viertes Quartal mit 3,1 Mio. EUR Umsatz (+17%) führt zu 9 % Umsatzwachstum im Geschäftsjahr 2019 - Meilensteine bei Schlüsseltechnologien Silberbeschichtung und magnesiumbasierte Implantate](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
DGAP-News: aap Implantate AG: GJ/19: Gutes viertes Quartal mit 3,1 Mio. EUR Umsatz (+17%) führt zu 9 % Umsatzwachstum im Geschäftsjahr 2019 - Meilensteine bei Schlüsseltechnologien Silberbeschichtung und magnesiumbasierte Implantate
DGAP-News: aap Implantate AG: GJ/19: Gutes viertes Quartal mit 3,1 Mio. EUR Umsatz (+17%) führt zu 9 % Umsatzwachstum im Geschäftsjahr 2019 - Meilensteine bei Schlüsseltechnologien Silberbeschichtung und magnesiumbasierte Implantate
![DGAP-News: aap Implantate AG: FY/19: Good fourth quarter with EUR 3.1 million revenue (+17%) results in 9% revenue growth in fiscal year 2019 - Milestones in key technologies silver coating and magnesium-based implants](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
DGAP-News: aap Implantate AG: FY/19: Good fourth quarter with EUR 3.1 million revenue (+17%) results in 9% revenue growth in fiscal year 2019 - Milestones in key technologies silver coating and magnesium-based implants
DGAP-News: aap Implantate AG: FY/19: Good fourth quarter with EUR 3.1 million revenue (+17%) results in 9% revenue growth in fiscal year 2019 - Milestones in key technologies silver coating and magnesium-based implants
![Form 8.3 - The Vanguard Group, Inc.: Allergan plc](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
![Form 8.3 - The Vanguard Group, Inc.: Allergan plc](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
![Form 8.3 - The Vanguard Group, Inc.: Consort Medical plc](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
Form 8.3 - The Vanguard Group, Inc.: Consort Medical plc
Form 8.3 - The Vanguard Group, Inc.: Consort Medical plc
![Form 8.3 - The Vanguard Group, Inc.: Allergan plc](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
![DGAP-News: HumanOptics AG: Artificial iris from HumanOptics receives US health insurance approval](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
DGAP-News: HumanOptics AG: Artificial iris from HumanOptics receives US health insurance approval
DGAP-News: HumanOptics AG: Artificial iris from HumanOptics receives US health insurance approval
![DGAP-News: HumanOptics AG: Künstliche Iris von HumanOptics erhält US-Kassenzulassung](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
DGAP-News: HumanOptics AG: Künstliche Iris von HumanOptics erhält US-Kassenzulassung
DGAP-News: HumanOptics AG: Künstliche Iris von HumanOptics erhält US-Kassenzulassung
![Form 8.3 - The Vanguard Group, Inc.: Allergan plc](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
![Form 8.3 - The Vanguard Group, Inc.: Allergan plc](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
RHÖN-KLINIKUM AG sichert langfristigen Betrieb des Marburger Ionenstrahl-Therapiezentrums (MIT)
RHÖN-KLINIKUM AG sichert langfristigen Betrieb des Marburger Ionenstrahl-Therapiezentrums (MIT)
![Form 8.3 - The Vanguard Group, Inc.: Allergan plc](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
![DGAP-Adhoc: Drägerwerk AG & Co. KGaA: preliminary results for 2019 and guidance for 2020](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
DGAP-Adhoc: Drägerwerk AG & Co. KGaA: preliminary results for 2019 and guidance for 2020
DGAP-Adhoc: Drägerwerk AG & Co. KGaA: preliminary results for 2019 and guidance for 2020
![DGAP-Adhoc: Drägerwerk AG & Co. KGaA: Vorläufige Geschäftszahlen 2019 und Prognose 2020](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
DGAP-Adhoc: Drägerwerk AG & Co. KGaA: Vorläufige Geschäftszahlen 2019 und Prognose 2020
DGAP-Adhoc: Drägerwerk AG & Co. KGaA: Vorläufige Geschäftszahlen 2019 und Prognose 2020
![Form 8.3 - The Vanguard Group, Inc.: Allergan plc](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
![Form 8.3 - The Vanguard Group, Inc.: Allergan plc](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
![Form 8.3 - The Vanguard Group, Inc.: Allergan plc](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
![Form 8.3 - The Vanguard Group, Inc.: Allergan plc](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
![Form 8.3 - The Vanguard Group, Inc.: Allergan plc](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
![EQS-Adhoc: AEVIS VICTORIA SA: Swiss Medical Network enters in the capital of Hôpital du Jura bernoishttp://www.aevis.com: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12720/aevis-logo.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBbEFDIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--507b344b1f20eff6a87ec7cc44acfa0f3e7ed125/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/aevis-logo.png?locale=de)
EQS-Adhoc: AEVIS VICTORIA SA: Swiss Medical Network enters in the capital of Hôpital du Jura bernois
EQS-Adhoc: AEVIS VICTORIA SA: Swiss Medical Network enters in the capital of Hôpital du Jura bernois
![EQS-Adhoc: AEVIS VICTORIA SA: Swiss Medical Network beteiligt sich am Aktionariat der Hôpital du Jura bernoishttp://www.aevis.com: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12720/aevis-logo.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBbEFDIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--507b344b1f20eff6a87ec7cc44acfa0f3e7ed125/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/aevis-logo.png?locale=de)
EQS-Adhoc: AEVIS VICTORIA SA: Swiss Medical Network beteiligt sich am Aktionariat der Hôpital du Jura bernois
EQS-Adhoc: AEVIS VICTORIA SA: Swiss Medical Network beteiligt sich am Aktionariat der Hôpital du Jura bernois
![Form 8.3 - The Vanguard Group, Inc.: Allergan plc](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
![Form 8.3 - The Vanguard Group, Inc.: Allergan plc](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
![Form 8.3 - The Vanguard Group, Inc.: Allergan plc](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Form 8.3 - The Vanguard Group, Inc.: Allergan plc